Genmab | Ventes



Sales Changement Date
Agios Pharmaceuticals USD 12.45M 3.75M 2025-06
Almirall EUR 275M 9.6M 2025-06
Amarin USD 72.74M 30.72M 2025-06
Amgen USD 8.15B 936M 2025-03
argenx SE USD 842.5M 132.26M 2025-06
AstraZeneca USD 14.46B 867M 2025-06
Bayer EUR 13.74B 2.01B 2025-03
BioMarin Pharmaceutical USD 745M 2.31M 2025-03
Demant DKK 5.62B 40M 2024-12
Exelixis USD 568.3M 12.9M 2025-06
Fresenius Medical Care EUR 4.88B 190M 2025-03
Galapagos EUR 70.17M 4.81M 2025-06
Genmab DKK 5.28B 59.13B 2025-03
GlaxoSmithKline GBP 7.99B 470M 2025-06
GN Store Nord DKK 3.99B 1.03B 2025-03
GRIFOLS EUR 1.89B 100M 2025-06
Hikma Pharmaceutical USD 1.59B 18M 2024-12
Insmed USD 92.82M 11.62M 2025-03
Lonza CHF 3.58B 63M 2025-06
Merck EUR 5.28B 138M 2025-03
Novartis USD 14.05B 821M 2025-06
Regeneron Pharmaceuticals USD 3.03B 760M 2025-03
Roche Holding CHF 31.64B 883M 2024-12
Sanofi EUR 9.99B 90M 2025-06
UCB EUR 3.36B 570M 2024-12


Genmab Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.